Virtu Financial LLC Purchases New Shares in The Clorox Company $CLX

Virtu Financial LLC purchased a new position in The Clorox Company (NYSE:CLX) during the 4th quarter, HoldingsChannel.com reports. The fund purchased 6,071 shares of the company’s stock, valued at approximately $612,000.

A number of other institutional investors have also added to or reduced their stakes in CLX. Vermillion & White Wealth Management Group LLC purchased a new stake in shares of Clorox in the 3rd quarter worth about $25,000. Darwin Wealth Management LLC purchased a new position in Clorox during the 2nd quarter valued at about $29,000. Caitlin John LLC boosted its stake in Clorox by 1,807.1% during the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after acquiring an additional 253 shares in the last quarter. Ameriflex Group Inc. boosted its stake in Clorox by 1,436.8% during the third quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock worth $36,000 after acquiring an additional 273 shares in the last quarter. Finally, Vision Financial Markets LLC grew its holdings in Clorox by 166.7% in the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares during the period. Institutional investors own 78.53% of the company’s stock.

Insider Activity at Clorox

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of the firm’s stock in a transaction dated Tuesday, May 5th. The stock was purchased at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 0.63% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on CLX. TD Cowen lifted their target price on shares of Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a report on Tuesday, March 31st. Citigroup cut their price target on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. Morgan Stanley reduced their price objective on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research report on Friday, May 1st. Zacks Research downgraded Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. Finally, Evercore reissued an “underperform” rating and issued a $110.00 target price on shares of Clorox in a research note on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat, Clorox has an average rating of “Reduce” and an average target price of $103.40.

Clorox Trading Down 5.4%

Shares of NYSE CLX opened at $90.61 on Tuesday. The firm’s 50 day moving average price is $95.37 and its 200-day moving average price is $104.70. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The company has a market cap of $10.96 billion, a PE ratio of 14.71, a P/E/G ratio of 0.50 and a beta of 0.56.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter last year, the firm earned $1.45 earnings per share. The firm’s quarterly revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities research analysts expect that The Clorox Company will post 5.61 EPS for the current fiscal year.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.